Healthcare

The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...

This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...

The healthcare market in Asia-Pacific (APAC) is expected to grow by 7.2% in 2019 due to the growth of smart hospitals and developments in the home care segment and medical tourism. This, in turn, has increased the demand for technology, innovative healthcare programmes, as well as drugs and medical devices based on advanced technology. Conventional...

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At ...

The Asia-Pacific medical imaging industry is in the growth stage. Both established and new medical imaging manufacturers in the region are constantly focusing on innovating new products, while simultaneously looking at ways to reduce the cost incurred for placing their products. Using these manufacturers as partners or joint venture participants of...

21 Aug 2018  |  Asia Pacific

Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023

Product Innovation is the Answer for Sustainability in a Dynamic Market

Infographics

×

The governments and providers in Asia-Pacific (APAC) are focused on reducing medical expenses while improving population health and well-being. A shortage of medical professionals is seen across multiple specialties in various APAC countries; moreover, clinicians are concentrated in urban areas leading to disproportionate clinician–to-patient rat...

Population Health Management (PHM) has many connotations ranging from an ideal or a concept to a real market segment. As a concept it refers to the reduction of disease risk and the attached financial burden at a population level. Execution of the concept entails intricate interaction between telehealth technologies, software solutions, and healthc...

16 Apr 2018  |  Asia Pacific

Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021

Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market

Infographics

×

Key Issues Addressed

Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...